FI952805A - Acetosalicylic acid transdermal delivery system for antithrombotic therapy and cancer prevention - Google Patents

Acetosalicylic acid transdermal delivery system for antithrombotic therapy and cancer prevention Download PDF

Info

Publication number
FI952805A
FI952805A FI952805A FI952805A FI952805A FI 952805 A FI952805 A FI 952805A FI 952805 A FI952805 A FI 952805A FI 952805 A FI952805 A FI 952805A FI 952805 A FI952805 A FI 952805A
Authority
FI
Finland
Prior art keywords
delivery system
transdermal delivery
cancer prevention
antithrombotic therapy
acetosalicylic acid
Prior art date
Application number
FI952805A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI120719B (en
FI952805A0 (en
Inventor
Frank Becher
Thomas Kissel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4241128A external-priority patent/DE4241128C2/en
Priority claimed from PCT/EP1993/003231 external-priority patent/WO1994013302A1/en
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of FI952805A0 publication Critical patent/FI952805A0/en
Publication of FI952805A publication Critical patent/FI952805A/en
Application granted granted Critical
Publication of FI120719B publication Critical patent/FI120719B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI952805A 1992-12-07 1995-06-07 A process for the preparation of a transdermal system containing acetylsalicylic acid FI120719B (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4241128 1992-12-07
DE4241128A DE4241128C2 (en) 1991-12-20 1992-12-07 Use of a transdermal administration system which contains acetylsalicylic acid and / or pharmaceutically acceptable salts thereof as active ingredient
PCT/EP1993/003231 WO1994013302A1 (en) 1991-12-20 1993-11-18 Transdermal administration system containing acetylsalicylic acid for antithrombotic therapy and the prevention of cancer
EP9303231 1993-11-18

Publications (3)

Publication Number Publication Date
FI952805A0 FI952805A0 (en) 1995-06-07
FI952805A true FI952805A (en) 1995-06-07
FI120719B FI120719B (en) 2010-02-15

Family

ID=6474576

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952805A FI120719B (en) 1992-12-07 1995-06-07 A process for the preparation of a transdermal system containing acetylsalicylic acid

Country Status (14)

Country Link
EP (1) EP0671916A1 (en)
JP (1) JP3799502B2 (en)
AU (1) AU694410B2 (en)
CA (1) CA2150033A1 (en)
CZ (1) CZ149495A3 (en)
FI (1) FI120719B (en)
HR (1) HRP931474A2 (en)
HU (1) HUT75680A (en)
IL (1) IL107867A (en)
NO (1) NO952234L (en)
NZ (1) NZ258129A (en)
PL (1) PL174770B1 (en)
SK (1) SK75495A3 (en)
ZA (1) ZA939126B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064841A1 (en) * 2003-01-23 2004-08-05 Shire Holdings Ag Formulation and methods for the treatment of thrombocythemia
EP1716854A4 (en) 2004-02-16 2010-01-20 Teikoku Seiyaku Kk External preparation for treating painful skin wound
US7910597B2 (en) 2006-11-28 2011-03-22 Shire Llc Substituted quinazolines
US8304420B2 (en) 2006-11-28 2012-11-06 Shire Llc Substituted quinazolines for reducing platelet count
JP6720257B2 (en) * 2018-09-05 2020-07-08 テックフィールズ インコーポレイテッド NSAIA prodrugs with very fast skin and membrane penetration rates and novel pharmaceutical uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2496459A1 (en) * 1980-12-19 1982-06-25 Astier Laboratoires Docteur P PHARMACEUTICAL COMPOSITION IN THE FORM OF A GEL CONTAINING ACETYLSALICYLIC ACID
IL68965A (en) * 1983-06-13 1987-02-27 Rafa Labor Ltd Topical pharmaceutical preparation comprising acetylsalicylic acid for the treatment of dermatological disorders
HRP921157A2 (en) * 1991-12-20 1994-10-31 Lohmann Therapie Syst Lts Transdermal system of applying acetilsalicilyc acid in antithrombosys therapy

Also Published As

Publication number Publication date
NZ258129A (en) 1999-10-28
CA2150033A1 (en) 1994-06-23
IL107867A0 (en) 1994-04-12
NO952234D0 (en) 1995-06-06
AU694410B2 (en) 1998-07-23
HRP931474A2 (en) 1994-12-31
SK75495A3 (en) 1996-05-08
PL309285A1 (en) 1995-10-02
CZ149495A3 (en) 1996-03-13
PL174770B1 (en) 1998-09-30
JPH08504198A (en) 1996-05-07
ZA939126B (en) 1994-08-05
IL107867A (en) 1998-08-16
HUT75680A (en) 1997-05-28
AU5563294A (en) 1994-07-04
HU9501641D0 (en) 1995-08-28
FI120719B (en) 2010-02-15
EP0671916A1 (en) 1995-09-20
JP3799502B2 (en) 2006-07-19
FI952805A0 (en) 1995-06-07
NO952234L (en) 1995-06-06

Similar Documents

Publication Publication Date Title
GB2163347B (en) Transdermal drug delivery system
AU5167993A (en) Failsafe iontophoresis drug delivery system
AU4370593A (en) Tissue-specific implantable therapeutic agent delivery system
AU4449789A (en) Delivery system for pharmaceutical or therapeutic actives
EP0237263A3 (en) Transdermal drug delivery system
DE59209886D1 (en) Implantable defibrillation system
DE69313510D1 (en) Delivery catheter
AU5397996A (en) Iontophoretic transdermal system for the administration of at least two substances
AU2816589A (en) Self-regulated therapeutic agent delivery system and method
DE59308186D1 (en) IMPLANTABLE DEFIBRILLATION SYSTEM
EP0707471A4 (en) Novel therapeutic drug delivery systems
EP0654973A4 (en) System of drug delivery to the lymphatic tissues.
DE59307855D1 (en) Defibrillation system
KR950700749A (en) Method of treating cancer by conjunctive therapy with 2'-halomethylidene derivatives and a S-phase or M phase specific antineoplastic agent)
FI942922A (en) Acetylsalicylic acid transdermal delivery system for antithrombotic therapy and cancer prevention
DK19893A (en) NASAL TREATMENT PREPARATION
AU6226894A (en) Implantable therapy systems and methods
KR950700707A (en) Dental treatment system
DE69214558D1 (en) Cancer therapy system
EP0729370A4 (en) Iontophoretic drug delivery system and method
NO973292D0 (en) On-line drug delivery system in extracorporeal therapy
FI952805A0 (en) Acetosalicylic acid transdermal delivery system for antithrombotic therapy and cancer prevention
ZA932303B (en) Medicament for the treatment of airways inflammation and airways hyperresponsiveness
ZA931700B (en) Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients
IE853178L (en) Transdermal delivery system for administering timol

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 120719

Country of ref document: FI

MM Patent lapsed